NCT07200128View on ClinicalTrials.gov

A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Severe Alopecia Areata
Interventions
DRUG

Ritlecitinib

As provided in real world practice

Trial Locations (1)

10001

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07200128 - A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings | Biotech Hunter | Biotech Hunter